Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 13/20 | 0.57 |
| ▸ | SELP | P16109 | 8/20 | 0.43 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.37 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12942287 | 0.94 | SELE (0.57) | SELESELP | |
| SCHEMBL12942205 | 0.92 | SELE (0.56) | SELESELP | |
| SCHEMBL9613569 | 0.89 | SELE (0.55) | SELESELP | |
| SCHEMBL9613582 | 0.86 | SELE (0.52) | SELESELP | |
| SCHEMBL12945076 | 0.84 | SELE (0.51) | SELESELP | |
| SCHEMBL13824366 | 0.83 | SELE (0.49) | SELESELPLGALS9LGALS1LGALS3 | |
| SCHEMBL12257313 | 0.82 | SELE (0.72) | SELESELP | |
| SCHEMBL14217735 | 0.82 | SELE (0.74) | SELESELP | |
| SCHEMBL11981958 | 0.81 | SELE (0.79) | SELESELP | |
| SCHEMBL9613545 | 0.81 | SELE (0.57) | SELESELPLGALS9LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2457573-A1 | Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines | GlycoMimetics, Inc. (US) | 2012-05-30 | — | — | EP | disclosed |
| WO-2008100453-A1 | METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES | GLYCOMIMETICS, INC. (US) | 2008-08-21 | — | — | WO | disclosed |